Using Genomics to Prevail in Toxic Tort Litigation

Posted by on June 19, 2017

Over the past several decades, genomic science revolutionized the practice of criminal law and is now in the process of transforming civil law. While the use of genetic science in criminal law tended to focus on relatively narrow issues, the genetic revolution in civil law is likely to lead to far wider ranging implications, including causation, foreseeability, compensation, ethics and risk management.
Read More

Presenting The Science Is Key In Talc Trials

Posted by and on June 13, 2017

Establishing a rigorous and reliable causal inference between an exposure and an adverse health outcome is one of the most difficult things to do in the health sciences. However, it is sometimes even more difficult to effectively and appropriately demonstrate that a causal relationship does not exist.
Read More

Streaming Video Testimony Sheds Light on Role of Science in California Talc Litigation

Posted by and on June 5, 2017

Every February 28th, India celebrates National Science Day in honor the  Indian physicist Sir Chandrashekhara Venkata, who discovered the Raman effect. The United States has no equivalent celebration, but “Science Days” have become a commonplace in complex state and federal Litigations, around the country.
Read More


Posted by on April 4, 2017

It is our experience that many attorneys and their teams struggle to keep up with new science in a systematic and organized fashion. However, we have also encountered scientific savvy firms that are up-to-date on the science and hard at work analyzing and developing new legal strategies based on the emerging science. This latter group is best-positioned to provide their clients with the best science-based defense.
Read More

Experts On The Experts: A Deep Dive Into The Make-or-Break Scientific Testimony Deciding Talc Powder Trials

Posted by on March 9, 2017

This article previously appeared on Courtroom View Network.
Read More

Will EU Regulatory Battles Over Endocrine Disruptors Translate to US Litigation?

Posted by on March 3, 2017

There is a battle raging in the European Union on an issue that is recognized in the US only by environmental scientists, policy wonks, and activists: the regulatory status of endocrine disrupting chemicals. As we have written before, this debate could have dramatic implications for litigation in the US. Such litigation could involve claims that
Read More


Posted by on February 15, 2017

As any good toxic tort litigator knows, it is not enough for a defendant to demonstrate that the alleged harmful chemical was not the cause of the injury. Rather, an effective defense provides the jury with a reasonable explanation as to what the cause of the injury was. Genomic data offer the defense just such
Read More

Adverse Drug Events from Social Media: 4 Reasons Pharmaceutical and Medical Device Companies Need to have a Plan

Posted by on January 30, 2017

This article was co-authored by Josephine Borrillo, a Digital Health Consultant that advises healthcare enterprises on best practices for the development, adoption, and marketing of digital health technologies.
Read More

Was There Exposure? Objective Tests Through Advances in Biomarker Science Relevant to Asbestos and Other Toxic Tort Litigation

Posted by on January 10, 2017

This article was authored by Giovanni Ciavarra, PhD and Kirk Hartley, Esq.  This post previously appeared on The Goldberg Segalla Asbestos Case Tracker.
Read More

WEBINAR: Genetic Susceptibility, Exposure Markers, and the Talc Experience

Posted by on January 3, 2017

Innovative Science Solutions will be speaking at the upcoming Toxic Torts and Product Liability Webinar to be hosted by Mayer Brown on Thursday, January 19, 2017 (1:00 p.m. – 2:30 p.m. EST).   Emerging Science and Toxic Tort Litigation: Genetic Susceptibility, Exposure Markers, and the Talc Experience   The webinar features a presentation by Dr.
Read More